Investigation of 20S-hydroxyvitamin D3 analogs and their 1α-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities
暂无分享,去创建一个
Duane D. Miller | N. Rochel | Wei Li | A. Slominski | R. Tuckey | A. Postlethwaite | Zongtao Lin | Tae-Kang Kim | Z. Janjetovic | S. R. Marepally | Emily S. Y. Goh | C. Cheng | C. Peluso‐Iltis
[1] A. Jetten,et al. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as “biased” agonists on VDR and inverse agonists on RORα and RORγ , 2017, The Journal of Steroid Biochemistry and Molecular Biology.
[2] Duane D. Miller,et al. 1α,20S-Dihydroxyvitamin D3 Interacts with Vitamin D Receptor: Crystal Structure and Route of Chemical Synthesis , 2017, Scientific Reports.
[3] C. Elmets,et al. On the role of classical and novel forms of vitamin D in melanoma progression and management , 2017, The Journal of Steroid Biochemistry and Molecular Biology.
[4] Duane D. Miller,et al. Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer. , 2016, Journal of medicinal chemistry.
[5] Wei Li,et al. Classical and non‐classical metabolic transformation of vitamin D in dermal fibroblasts , 2016, Experimental dermatology.
[6] Duane D. Miller,et al. Design, Synthesis and Biological Activities of Novel Gemini 20S-Hydroxyvitamin D3 Analogs. , 2016, Anticancer research.
[7] Duane D. Miller,et al. Total synthesis of biologically active 20S-hydroxyvitamin D3 , 2015, Steroids.
[8] Wei Li,et al. Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland , 2015, Scientific Reports.
[9] Duane D. Miller,et al. Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1α-Hydroxyl Derivatives. , 2015, Journal of medicinal chemistry.
[10] Jin Wang,et al. Novel activities of CYP11A1 and their potential physiological significance , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[11] Wei Li,et al. Metabolism of 20-hydroxyvitamin D3 and 20,23-dihydroxyvitamin D3 by rat and human CYP24A1 , 2015, The Journal of Steroid Biochemistry and Molecular Biology.
[12] A. Piotrowska,et al. The renaissance of vitamin D. , 2014, Acta biochimica Polonica.
[13] Wei Li,et al. The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[14] R. Tuckey,et al. Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24‐oxidation pathway , 2014, The FEBS journal.
[15] Jin Wang,et al. RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20‐hydroxy‐ and 20,23‐dihydroxyvitamin D , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Wei Li,et al. Hydroxylation of CYP11A1-Derived Products of Vitamin D3 Metabolism by Human and Mouse CYP27B1 , 2013, Drug Metabolism and Disposition.
[17] Jin Wang,et al. 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo. , 2013, The Journal of clinical endocrinology and metabolism.
[18] Wei Li,et al. Rat CYP24A1 acts on 20-hydroxyvitamin D(3) producing hydroxylated products with increased biological activity. , 2012, Biochemical pharmacology.
[19] Duane D. Miller,et al. Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength , 2012, Molecular and Cellular Endocrinology.
[20] A. Slominski,et al. Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes. , 2012, Anticancer research.
[21] Wei Li,et al. In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] L. Pfeffer,et al. High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives , 2011, British Journal of Cancer.
[23] D. Baldisseri,et al. Production of 22-Hydroxy Metabolites of Vitamin D3 by Cytochrome P450scc (CYP11A1) and Analysis of Their Biological Activities on Skin Cells , 2011, Drug Metabolism and Disposition.
[24] D. Moras,et al. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. , 2011, MedChemComm.
[25] Duane D. Miller,et al. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. , 2011, American journal of physiology. Cell physiology.
[26] D. Feldman,et al. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. , 2011, Annual review of pharmacology and toxicology.
[27] H. DeLuca,et al. Vitamin D, disease and therapeutic opportunities , 2010, Nature Reviews Drug Discovery.
[28] Duane D. Miller,et al. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity , 2010, Steroids.
[29] Wei Li,et al. Purified Mouse CYP27B1 Can Hydroxylate 20,23-Dihydroxyvitamin D3, Producing 1α,20,23-Trihydroxyvitamin D3, Which Has Altered Biological Activity , 2010, Drug Metabolism and Disposition.
[30] R. Tuckey,et al. Metabolism of substrates incorporated into phospholipid vesicles by mouse 25-hydroxyvitamin D3 1α-hydroxylase (CYP27B1) , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[31] Duane D. Miller,et al. Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity , 2010, PloS one.
[32] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[33] A. Slominski,et al. 20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytes , 2009, Journal of cellular physiology.
[34] L. Pfeffer,et al. 20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes , 2009, PloS one.
[35] S. Chandrasekhar,et al. Beta-sugar aminoxy peptides as rigid secondary structural scaffolds. , 2008, The Journal of organic chemistry.
[36] A. Slominski,et al. 20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. , 2008, The Journal of investigative dermatology.
[37] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[38] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[39] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.